Andrew is a lawyer and the co-founder of CBD Pharmaceuticals and AltMed. Andrew was an Associate at the law firm Corrs Chambers Westgarth where he practised regulatory and commercial litigation.
He now directs CBD Pharmaceuticals and has a special interest in the therapeutic role of minor cannabinoids and terpenes. In his spare time, Andrew follows legal developments abroad regarding the regulation of cannabis. He is keen to see legal reform in Australia that improves patient access to plant-based medicines.